Back to search
FDAFDA · Food and drugs·Recall number D-0251-2015

Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX

Published November 26, 2014 · Recall initiated: April 19, 2013

Summary

FDA records drug Class I recall D-0251-2015, published November 26, 2014 and initiated April 19, 2013. Recalling firm: Abrams Royal Pharmacy; Status: Terminated; Reported quantity: 50 syringes; Lot: Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-Sterility

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Abrams Royal Pharmacy
Distributor
Texas
Lot
Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX recalled?

Yes. FDA published recall D-0251-2015 on November 26, 2014. Reported hazard: Non-Sterility

What should I do if I have this product?

Voluntary: Firm initiated · Telephone